Detalles de la búsqueda
1.
Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults.
BMJ Open
; 5(10): e008748, 2015 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26510727
Resultados
1 -
1
de 1
1
Próxima >
>>